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A B S T R A C T
A point of care device utilising Lab-on-a-Chip technologies that is applicable for biological pathogens was de-
signed, fabricated and tested showing sample in to answer out capabilities. The purpose of the design was to
develop a cartridge with the capability to perform nucleic acid extraction and purification from a sample using a
chitosan membrane at an acidic pH. Waste was stored within the cartridge with the use of sodium polyacrylate to
solidify or gelate the sample in a single chamber. Nucleic acid elution was conducted using the RPA amplifi-
cation reagents (alkaline pH). Passive valves were used to regulate the fluid flow and a multiplexer was designed
to distribute the fluid into six microchambers for amplification reactions. Cartridges were produced using soft
lithography of silicone from 3D printed moulds, bonded to glass substrates. The isothermal technique, RPA is
employed for amplification. This paper shows the results from two separate experiments: the first using the RPA
control nucleic acid, the second showing successful amplification from Chlamydia Trachomatis.
Endpoint analysis conducted for the RPA analysis was gel electrophoresis that showed 143 base pair DNA was
amplified successfully for positive samples whilst negative samples did not show amplification. End point
analysis for Chlamydia Trachomatis samples was fluorescence detection that showed successful detection of 1
copy/μL and 10 copies/μL spiked in a MES buffer.
Introduction
Point of care (POC) diagnostics for molecular diagnostics have been
the focus of many research projects since the beginning of the century.
Whilst the GeneXpert has seen success, the four module platform has
never been seen as truly point of care. This has changed with the advent
of the GeneXpert Omni – a portable battery powered POC diagnostic;
however the limitation to run a single diagnostic in one run is a lim-
itation and benchtop sample preparation is still required [1]. POC de-
vices such as the GeneXpert use nucleic acid (NA) amplification for the
detection of pathogens. This paper focuses on the amplification of
double stranded nucleic acid, deoxyribonucleic acid (DNA) found in
bacteria. The GeneXpert uses the most common method for NA detec-
tion, polymerase chain reaction (PCR) [2]. PCR requires thermal cy-
cling through three reaction temperatures 95, 50 and 72 °C. Two pri-
mers are required for PCR, nucleic acid is doubled in each thermal
cycle, overall the reaction is slower than isothermal equivalents and the
requirement for thermal cycling has made it a less popular solution at
the point of care due to the high power requirements [3,4]. Fluidic
devices have been developed incorporating PCR using fluorescence
markers, capillary gel electrophoresis and DNA microarrays with vo-
lumes ranging from 4 to 50 μL [4].
Isothermal techniques amplify nucleic acids at a single temperature
and have been shown as an alternative to PCR. The techniques can be
integrated with gel electrophoresis, optical detection and more recently
nucleic acid over lateral flow (NALF) [5–7]. The low power consump-
tion required allows the devices to be run using batteries making them
portable, low cost and of use in the developing world. Loop mediated
amplification (LAMP) uses a set of four primers, a forward inner primer,
a backward inner primer and two outer primers. It produces an ex-
ponential amplification of the target sequence and produces a com-
parable number of copies (109) of DNA to PCR within 1 h at 60–65 °C.
LAMP can be integrated with colorimetric dyes for ease of detection.
Helicase dependent amplification (HDA) utilizes the helicase enzyme to
replicate DNA. The method operates at 60–65 °C and incorporates
template separation through unwinding of dsDNA, this is followed by
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the forward and reverse primers binding and polymerase elongation;
the process then repeats asynchronously. The process takes 60min for
106 fold amplification. Assay design is comparatively simple, however
the process is slow and amplification has shown relatively low copy
numbers. NASBA is a method used in RNA detection, it is therefore of
greater use in viral diagnostics; amplification forms cDNA from an RNA
template. The process takes 90min to produce 109 copies of DNA for
detection and the operating temperature is low, 41 °C, however, to re-
duce non-specific amplification a prior step of 65 °C is required. Rolling
circle amplification (RCA) is a low temperature, 37 °C, enzymatic
method that uses strand displacement through the polymerase activity
of the Phi29 bacteriophage DNA polymerase. RCA shows amplification
of 103 in 1 h and can be detected using fluorophores or gel electro-
phoresis [5,8].
Recombinase Polymerase Amplification (RPA) is an isothermal
process that utilizes two primers, the reaction runs at temperatures
between 37 and 42 °C. RPA can be run rapidly with results being shown
in 10min with complete runs for low copy numbers taking around
30min to complete. The number of copies produced is 109-1011 which
is comparable, if not higher than conventional PCR. RPA can be in-
tegrated with NALF and gel electrophoresis, optical detection is con-
ducted using a fluorophore. The main advantages of RPA is its simpli-
city, using only two primers simplifying, primer design, rapid detection
time, low operating temperature and the different detection techniques
that can be utilized making this a versatile assay for use at the point of
care [9–12].
Within the developing world there is a need for new diagnostics at
the point of care that are low cost, do not require mains power and are
modular. The device presented in this paper is a battery operated,
handheld, molecular diagnostic platform that has shown isothermal
techniques including HDA [3] and RPA. The handheld device is low
cost being fabricated using 3D printed enclosure and off the shelf
electronic components, an Arduino Mega is used for electronic control.
Three custom boards and PCB spacers make up the main structural
isothermal platform. The design, manufacture and tests of a fluidic are
shown using the RPA positive reaction kit and then using Chlamydia
Trachomatis (CT) cells spiked into an MES buffer solution.
Materials and methods
Fluidic cartridge design and fabrication
The fluidic cartridges of 75×50mm, were designed using the
Ansys multiphase CFD simulation software. In the fluidic cartridge
(Fig. 1a), there are three reaction chambers. The first is the central
reaction chamber that has a volume of 0.65 μL and houses the chitosan
membrane, which has a thickness of 100 μm. The chitosan membrane
was utilized for DNA extraction on the cartridge. Chitosan is a poly-
saccharide that can be used for nucleic acid extraction. It has been
shown to adsorb DNA in microfluidic devices as it becomes cationic
when in acidic conditions due to the protonation of amino groups; when
in alkaline conditions DNA is released as protonation no longer occurs
neutralising the membrane [13,14]. This reduces the complexity of
sample preparation. The second reaction chamber was the waste
chamber where bio-waste due to DNA purification in the central
chamber was flushed and gelified with sodium polyacrylate, a super-
absorbent powder. This waste reservoir has a capacity of 200 μL. The
final reaction chambers were designated for the amplification reaction
and each have a total volume of 25 μL.
A passive valve was developed and implemented for precise flow
regulation, contamination reduction and to provide satisfactory DNA
yield. This was expected to redirect unwanted fluid towards the waste
chamber for treatment and then, once full, direct fluid towards the
amplification chambers. The purpose of the passive device was critical
to avoid complicated fluid control devices such as active fluid valves.
The functionality of the passive valve design is dependent on three key
factors. The first two were geometrically constrained features that in-
volve the use of a narrower channel to bridge to similar channels of
equal geometries. Whilst the other features were the accumulation of
dead volume as fluids transition from a large domain to a smaller re-
gion. The third factor is the surface properties of a hydrophobic sub-
strate that provide sufficient resistance due to unregulated flow by
capillarity. As a result, pressure variation becomes the only means to
propel and control flow. The general fluidic channel dimension was
1×0.5mm whilst the passive valve had a dimension of 0.3× 0.5mm.
Fig. 1. Overview of the fluidic device; (a) Fluidic components showing specific areas for sample input, nucleic acid purification (chitosan membrane), waste storage and amplification/
detection; (b) a cured PDMS device attached to 3D printed positive mould; (c) a fabricated device prior to testing incorporating the chitosan membrane and sodium polyacrylate.
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The final modular element was the multiplexer into which DNA must
flow from the passive valves. The multiplexer, designed using Ansys
CFD software was tested and allowed accurate filling of all six cham-
bers. The amplification chambers were designed empirically to avoid
bubble formation [3]. All the modular elements inclusive of the
chamber and the micro channels were fabricated with a standard re-
plication moulding techniques, soft lithography from 3D printed
moulds [3]. The use of 3D printing allowed rapid turnaround time of
moulds.
The positive master mould has dimensions 70×90mm and was
drawn using the CAD package Solidworks 2015 (Dassault Systems) and
manufactured using 3D printing on a Viper SLA (3D Systems, USA).
Dow Corning's Sylgard 184 was used to create the fluidic channels and
chambers. This two-part chemical system involves a mix ratio of cross-
linking agent A with siloxane agent B. The mix ratio was 1:10 (Part A:
Part B). Upon mixing, the (poly)dimethylsiloxane (PDMS) solution was
Fig. 2. (a) A graphical overview of the POC platform incorporating a USB battery, Arduino for electronic control and data capture, a joule heated stage, LEDs, light pipes and photodiodes;
(b) the completed platform showing the isothermal heater and internal components [3,16]. (c) The final device cycling through the RGB LEDs with mobile device (Samsung Galaxy S5) for
size comparison.
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rapidly stirred by hand for 1–2min and then placed in a vacuum de-
gassing chamber where the air is removed using an Edward's vacuum
pump at regular intervals for 15min. The degassed PDMS was poured
into the positive 3D printed mould and left to cure at 55 °C for 4 h. The
cured PDMS was removed from the mould (Fig. 1b); a chitosan mem-
brane was installed in the central reaction chamber, 10mg of sodium
polyacrylate was loaded into the waste chamber and 2.5 μl of magne-
sium acetate was loaded into each of the amplification reaction
chambers. Afterwards, a handheld corona treater, BD20-AC (Electro-
Technic Products Inc., US), was used to bond the PDMS to a
75× 50mm glass slide [15]. The treated surfaces of both substrates
were then pressed together and left untouched for at least 1 h at 45 °C
for the glass-PDMS surface interface to bond properly. Optimal bond
strength was observed when the glass-PDMS cartridge (Fig. 1c) was left
overnight. All reagents and glass slides were purchased from Sigma
Aldrich unless specifically stated.
Platform design and fabrication
A shoebox sized device was designed and developed with dimen-
sions of 290× 162×50mm (Fig. 2a). The device was manufactured
using an Objet 30 Pro 3D printer (Statasys, Germany). Three custom
circuit boards were designed using Eagle software. The boards in-
corporate an LED board for excitation of the fluorophore, which is
composed of six Avago tri-colour LEDs and a 60Ω resistor, the blue LED
is used for excitation of the fluorophore with a wavelength of 470 nm
[16]. The isothermal heater was modified from previous work [3], it
used a serpentine track and Joule heating via a high power MOSFET
(L2703). Eighteen surface mount resistors (TDK, 10 k ohm 1000 NTC)
were placed across the heater; although, only the six adjacent to the
amplification chambers were used to measure the temperature in ex-
periments. A bang-bang control programme was run via the Arduino to
control the isothermal heater. A 3mm aluminium plate was placed on
top of the isothermal circuit board using a heat transfer adhesive. This
ensured good thermal transfer across the entire fluidic device. The third
circuit board contains all components for fluorescence detection, all
components remain unchanged from Craw et al., this includes the
photodiode (BPW21, Centronic, UK), high gain operational amplifier
(OPA4750, Texas Instruments, USA) and a 1G ohm feedback resistor
[3]. A glass longpass filter (OG515, Schott, Germany) with a wave-
length cutoff of 515 nm was placed between the light pipe and the
photodiode. A fibre optic housing was 3D printed in VeroBlack to hold
six 3mm diameter light pipes, which transmit the signal from the am-
plification chamber to the photodiodes. The fibre optic housing and
threaded hex spacers brought the main body of the isothermal platform
together. All control and data acquisition was implemented via an Ar-
duino Mega. The Arduino Mega was powered by a 10 Ah USB battery
using 5 V DC and 1 A current. All electronic components were acquired
from RS, UK unless stated.
DNA extraction and amplification – RPA basic kit
Chitosan membranes were created by dissolving 1 w/v% chitosan in
2 v/v% acetic acid and stirred for 4 h. Whatman chromatography paper
was used as a substrate and was cut to shape using a cutting tool and
press, and placed in the solution with 1v/v% glutaraldehyde for 8 h.
Following cross linking of chitosan to the cellulose membrane, the
membranes were removed from solution, rinsed in a 10mM acetic acid
solution to remove any unbound chitosan and dried in an oven at 60 °C
for 1 h.
A 2-(N-morpholino)ethanesulfonic acid (MES) buffer (10mM) was
prepared at pH 5.0 for the RPA samples. The positive and negative
control DNA samples from the TwistAmp Basic kit (TwistDx, UK) were
used in first set of experiments to validate the fluidic design and
thermal stability of the platform. The original TwistDx assay was
modified to allow for extraction using the chitosan membrane and
larger volumes required (Table 1). Whilst each amplification chamber
only holds 25 μL, the total sample used for each reaction chamber was
50 μL to account for the extra volume required due to the chamfered
microfluidic inlets and outlets of the chambers. Positive and negative
Table 1
Comparisons between the original TwistDx chemical and volume compositions [17] with



















Tenth dilution of the
positive control
DNA (in dH2O)
10 μl MES buffer with
positive DNA
10 μl 80 μl
Primer A solution 4 μl Primer A
solution
4 μl 32 μl
Primer B solution 4 μl Primer B solution 4 μl 32 μl
Rehydration buffer 29.5 μl Rehydration
buffer





2.5 μl 20 μl
Total volume 50 μl 50 μl 400 μl
Table 2
Chlamydia trachomatis primer and probe sequences used for fpg RPA isothermal ampli-
fication assays.
Primer/Probe Name Size (bp) Sequence (5’ – 3′)
CDS2-FW (Forward
primer)




32 CTC TCA AGC AGG ACT ACA AGC TGC AAT
CCC TT
fpg modified Probe 33 [5′ BHQ1] GTT T [dR-FAM] T ACT CCG TCA
CAG CGG TTG CTC GAA GCA [3′-block]
Fig. 3. RPA amplicons detected by agarose gel electrophoresis using GelRed. The RPA
positive wells contained the positive sample provided with the TwistAmp Basic kit, the
negative control wells contained nuclease free water as the sample.
Fig. 4. RPA amplification curve of CT (1 copy/μL and 10 copies/μL), RPA positive control
and RPA negative control (nuclease free water).
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samples were run on different fluidic cartridges. The positive/negative
sample mixed with the MES buffer (80 μL) was flowed directly into the
chitosan chamber via inlet 1 (Fig. 1a) at a flow rate of 5 μL/s using
Fusion 100 syringe pump (KR Analytical, UK). Excess fluid flows to the
waste chamber, any remaining fluid was pushed into the waste chamber
by the use of pressurised air. Inlet 2 was opened at a flow rate of 5 μL/s
and the TwistDx rehydration buffer was released, the alkaline pH of the
rehydration buffer releases the DNA back into solution. The solution
was passed through the passive valve as the waste chamber was full and
solidified. Each chamber filled, the lyophilised was dissolved and am-
plification was performed at 44 °C. Gel electrophoresis was carried out
to analyse the outcome of the amplification experiment, a 3% agarose
gel stained with 0.5 μl GelRed ran for 1 h 22min at 75 V. TwistDx
positive sample DNA has an amplicon length of 143 base pairs (bp)
(± 10%). The ultralow gene ruler ladder ranging from 100 to 300 bp
was used at both ends of the gel to compare amplified products to a
standardised ladder. The gel depicts the combined results for both the
positive and negative controlled experiments.
DNA extraction and amplification – Chlamydia Trachomatis
An RPA assay using TwistAmp fpg targeting the gene of CDS2 of CT
was designed according to Krõlov et al. [10]. A sequence specific probe
for real time optical detection was designed as described in the test
manual [18]. The sequences of the primer sets and probe are indicated
in Table 2. The RPA reaction mixtures were made as previously de-
scribed in Section 2.3, however, the samples were now a positive
control, negative control, 1 copy/μL CT and 10 copies/μL CT (CT was
obtained from Zeptometrix, USA). A slightly alternative protocol was
used for this experiment samples as the cells required lysis. The 10mM
MES buffer was prepared at pH 3.0. The cartridge was placed in the
POC device, thermal heating initiated at 44 °C and data collection
begun.
Results and discussions
From six chambers run in each experiment a total of four samples
were successfully extracted for post amplification analysis from both
the RPA positive and negative experiment. Faint bands were shown for
positive samples, signifying evidence of DNA amplification within the
range of 100–200 bp, therefore in the range of the RPA positive control
of 143 bp (Fig. 3). The negative samples show no indication of DNA
amplification.
From the CT experiments, it can be seen that there was successful
amplification from the positive control along with both 10 and 1 copy/
μL of CT in MES buffer (Fig. 4). Amplification initiates within less than
5min, the positive control shows good amplification after 10min. For
10 copies/μL of CT optimal amplification occurs after 15min, the lower
copy number, 1 copy/μL takes longer, around 25min.
Both samples showed successful cell lysis in an acidic buffer, nucleic
acid extraction in a continuous, flow through device with waste col-
lected on the cartridge. The nucleic acid was successfully eluted using
the amplification rehydration buffer directly from the nucleic acid
membrane. Both experiments show the cartridge design to be optimal,
the passive valve worked repeatedly and amplification chambers filled,
six per run consecutively.
Conclusion
The work presented in the paper shows a fluidic cartridge that has
been modified for sample in to answer out detection using a POC system
and an RPA assay. The use of the chitosan membrane and use of the
RPA reagents for nucleic acid elution is of particular interest as it
simplifies the extraction and amplification process further than pre-
viously possible. Results for low copy numbers of CT were gained in
15–25min. Further work must be conducted using real, complex,
samples such as urine or urine with swab samples to ensure results can
be replicated.
The hybrid PDMS–glass fluidic cartridge for multiplex DNA ampli-
fication reactions showed good capabilities for extraction, waste col-
lection and sample splitting through the multiplexer prior to amplifi-
cation. The use of a single passive valve avoids the need for any active
valves. CFD was used successfully followed by numerous experiments to
design the multiplexer with the ability to split the fluid into six equal
parts without the need for any external valves.
The use of the Arduino is for prototyping purposes and allows for
rapid addition of modular elements and testing including control via a
mobile phone device using Bluetooth or visualisation of results on the
mobile screen. The platform that has been shown here has been used
with other isothermal assays including HDA making this a versatile
system. The platform is low cost and battery operated; whilst the device
can be held by hand it is still relatively large and in the current form
still requires the use of a desktop syringe pump.
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